These compounds may interact with:
Inhibitor of nuclear factor kappa-B kinase subunit beta
Potentially involved in: severe combined immunodeficiency; carcinoma; cancer; obesity; diabetes mellitus; arthritis; hyperglycemia; agammaglobulinemia; immunologic deficiency syndromes; respiratory tract infections; failure to gain weight; chronic diarrhea; infantile onset; pediatric failure to thrive; immunodeficiency 15; autosomal recessive predisposition; astrocytoma; astrocytoma, pilocytic; ependymoma; gaucher disease type 1
Disease data sourced from Pharos.